Proposing a new anti-Covid-19 agent by using molecular docking and dynamics simulations
Abstract The Covid-19 pandemic, caused by SARS-CoV-2, was responsible for millions of deaths worldwide. The main protease (Mpro) of SARS-CoV-2 is considered one of the important drug targets for the treatment of Covid-19. Recent studies have shown that anisotine should be a potent Mpro inhibitor. In...
Saved in:
Main Authors: | Izabella Rodrigues Fonseca da Silva, Luís Felipe Guerreiro Martins, Julliane Yoneda |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade de São Paulo
2025-01-01
|
Series: | Brazilian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502025000100326&lng=en&tlng=en |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of promising SARS-CoV-2 main protease inhibitor through molecular docking, dynamics simulation, and ADMET analysis
by: Ganesh Sharma, et al.
Published: (2025-01-01) -
In silico binding role of flavonoids as SARS-CoV-2 main protease (Mpro) inhibitors: A dataset of molecular docking simulation-based high-throughput virtual screening (HTVS)Mendeley Data
by: Mariyam Eema, et al.
Published: (2025-04-01) -
Computational and in vitro evaluation of sumac-derived ©Rutan compounds towards Sars-CoV-2 Mpro inhibition
by: Muzaffar Kayumov, et al.
Published: (2025-02-01) -
Computer-aided approaches reveal trihydroxychroman and pyrazolone derivatives as potential inhibitors of SARS-CoV-2 virus main protease
by: Atatreh Noor, et al.
Published: (2021-09-01) -
Exploring the antimicrobial and antioxidative potential of Leucas aspera (Willd.) link: Phytochemical screening, molecular docking, and HR-LC/MS profiling against SARS-CoV-2 protein 3CLPro, Spike and RDB
by: Thavasiaanatham Seenivasan Shalini, et al.
Published: (2025-02-01)